Features of optical coherence tomography angiography in age-related macular degeneration with residual fluid after three loading doses of aflibercept
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Features of optical coherence tomography angiography in age-related macular degeneration with residual fluid after three loading doses of aflibercept ; volume:11 ; number:1 ; day:1 ; month:2 ; year:2024 ; pages:1-8 ; date:12.2024
Eye and Vision ; 11, Heft 1 (1.2.2024), 1-8, 12.2024
- Urheber
-
Song, Yong-Yeon
Seong, Hyun-Je
Kim, Jung-Tae
Lee, Sung-Chul
Lee, Min-Woo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40662-023-00372-z
- URN
-
urn:nbn:de:101:1-2024031821040231015952
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Song, Yong-Yeon
- Seong, Hyun-Je
- Kim, Jung-Tae
- Lee, Sung-Chul
- Lee, Min-Woo
- SpringerLink (Online service)
Ähnliche Objekte (12)
The effect of four loading intravitreal aflibercept injections on macular fluid in treatment-naïve neovascular age-related macular degeneration
Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration
Therapeutic effects of faricimab on aflibercept-refractory age-related macular degeneration
Bilateral improvement in age-related macular degeneration following unilateral Aflibercept injection
Optical coherence tomography angiography biomarkers in a bi-monthly maintenance dosing aflibercept in patients with neovascular age-related macular degeneration
Macular Hole Surgery in the Case of Wet Age-Related Macular Degeneration Treated with Intravitreal Aflibercept
Intravitreal sirolimus with adjunct aflibercept versus aflibercept monotherapy for persistent, exudative age-related macular degeneration: a pilot study
Retinal vasculitis after intravitreal aflibercept 8 mg for neovascular age-related macular degeneration
Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab
Short-term choroidal vascular changes after aflibercept therapy for neovascular age-related macular degeneration
Four-Year Outcome of Aflibercept for Neovascular Age-Related Macular Degeneration and polypoidal choroidal vasculopathy
Three-year outcome of aflibercept treatment for Japanese patients with neovascular age-related macular degeneration
The effect of four loading intravitreal aflibercept injections on macular fluid in treatment-naïve neovascular age-related macular degeneration
Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration
Therapeutic effects of faricimab on aflibercept-refractory age-related macular degeneration
Bilateral improvement in age-related macular degeneration following unilateral Aflibercept injection
Optical coherence tomography angiography biomarkers in a bi-monthly maintenance dosing aflibercept in patients with neovascular age-related macular degeneration
Macular Hole Surgery in the Case of Wet Age-Related Macular Degeneration Treated with Intravitreal Aflibercept
Intravitreal sirolimus with adjunct aflibercept versus aflibercept monotherapy for persistent, exudative age-related macular degeneration: a pilot study
Retinal vasculitis after intravitreal aflibercept 8 mg for neovascular age-related macular degeneration
Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab
Short-term choroidal vascular changes after aflibercept therapy for neovascular age-related macular degeneration
Four-Year Outcome of Aflibercept for Neovascular Age-Related Macular Degeneration and polypoidal choroidal vasculopathy
Three-year outcome of aflibercept treatment for Japanese patients with neovascular age-related macular degeneration
The effect of four loading intravitreal aflibercept injections on macular fluid in treatment-naïve neovascular age-related macular degeneration
Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration
Therapeutic effects of faricimab on aflibercept-refractory age-related macular degeneration
Bilateral improvement in age-related macular degeneration following unilateral Aflibercept injection
Optical coherence tomography angiography biomarkers in a bi-monthly maintenance dosing aflibercept in patients with neovascular age-related macular degeneration
Macular Hole Surgery in the Case of Wet Age-Related Macular Degeneration Treated with Intravitreal Aflibercept
Intravitreal sirolimus with adjunct aflibercept versus aflibercept monotherapy for persistent, exudative age-related macular degeneration: a pilot study
Retinal vasculitis after intravitreal aflibercept 8 mg for neovascular age-related macular degeneration
Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab
Short-term choroidal vascular changes after aflibercept therapy for neovascular age-related macular degeneration
Four-Year Outcome of Aflibercept for Neovascular Age-Related Macular Degeneration and polypoidal choroidal vasculopathy